Instead of pushing blood flow, it nudges the brains arousal pathways
Fu EL, Mastrorilli J, Bykov K, Wexler DJ, Cervone A, Lin KJ, Patorno E, Paik JM (2024) A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes
Ongoing research on higher dosages of Rybelsus, reaching up to 50 mg, has shown results in weight reduction that are comparable with those of Wegovy (semaglutide), a medication specifically for weight loss
Ongoing: Continue indefinitely
Specifically, ANO6 upregulates ChaC1, associated with ferroptosis, by increasing intracellular iron and ROS levels, promoting lipid peroxidation and cell death
The most commonly cited range in off-label veterinary use is 2 to 10 mcg per kilogram of body weight per day